Effect of gonadal hormones on the plasma clearance and metabolite formation of antipyrine in the dwarf goat.
The effect of gonadal hormones on the plasma elimination and urinary metabolite profile of antipyrine was studied in dwarf goats. Female goats were treated with testosterone and male goats were treated with 17 beta-oestradiol. Castrated males were treated with either testosterone or 17 beta-oestradiol. Antipyrine (25 mg/kg, i.v.) was given both before and after the hormonal treatments. The effects of the hormonal status on the plasma elimination of the parent compound were not consistent. This was possibly due to the fact that formation of the main metabolite of antipyrine in the goat, 4-hydroxy antipyrine (OHA), was not affected by sex or hormonal treatment. On the other hand, there were clear effects of hormonal status on urinary excretion of the three other metabolites. In females and castrated males testosterone suppressed the formation of norantipyrine (NORA), 3-hydroxymethylantipyrine (HMA) and 4,4'-dihydroxyantipyrine (DOHA). Intact males produced smaller amounts of these metabolites than females. It is concluded that distinct xenobiotic metabolizing pathways exist in the dwarf goat, which are influenced in their activity by gonadal hormones. This confirms previous findings in rats and mice. The possibility that sex hormones influence drug metabolism in food-producing animals could have consequences for veterinary therapeutics and public health. This study also demonstrates that, when using the antipyrine test for the assessment of hepatic drug metabolism, it is very important to include the determination of metabolites.
Witkamp
R F
RF
Department of Veterinary Basic Sciences, Faculty of Veterinary Medicine, University of Utrecht, The Netherlands.
Nijmeijer
S M
SM
Kolker
H J
HJ
Noordhoek
J
J
van Miert
A S
AS
D000818:Animals; D000983:Antipyrine / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics*; D002369:Castration; D000077553:Edaravone; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D006041:Goats / Q000378:metabolism*; D008297:Male; D013739:Testosterone / Q000494:pharmacology*
C031820:3-hydroxymethylantipyrine; D013739:Testosterone; D004958:Estradiol; C033993:4,4'-dihydroxyantipyrine; D000077553:Edaravone; D000983:Antipyrine